EIQ.AX is trading 35.1% up at A$1.68 after announcing a strategic investment and U.S. distribution partnership with Pro Medicus.
- The deal provides up to A$20 million in secured convertible notes and debt funding, giving Echo IQ the capital required to accelerate its U.S. market expansion.
- A proposed U.S. reseller arrangement grants access to Pro Medicus’ established healthcare customer base, which investors view as a major commercial validation of the company's cardiology AI platform.